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Summary
Objective: Periosteal chondrogenesis is relevant to cartilage repair and fracture healing. Periosteum contains two distinct layers: a thick,
outer fibrous layer and a thin, inner cambium layer which is adjacent to the bone. Specific chondrocyte precursors are known to exist in
periosteum but have not yet been identified. In this study, the location of the chondrocyte precursors in periosteum was determined.
Method: One hundred and twenty periosteal explants from 30 2-month-old NZ rabbits were cultured for up to 42 days. Histomorphological
changes and spatio-temporal localization of Col. II mRNA and protein were analysed.
Results: On day 7, chondrocyte differentiation appeared in the most juxtaosseous region in the cambium layer. Col. II mRNA and protein
were also evident in the same region. By day 14, chondrocyte differentiation progressed further into the juxtaosseous cambium layer, as did
Col. II mRNA and protein. With growth of the neocartilage, the cambium layer gradually diminished to the extent that by 21–28 days it was
no longer evident. Cartilage growth was significant and followed an appositional pattern, growing away from the fibrous layer. The fibrous
layer remained essentially unchanged from 0–42 days, without evidence of hypertrophy or atrophy. Col. II mRNA expression was never seen
in the fibrous layer.
Conclusion: From these data, three conclusions can be drawn concerning chondrogenesis from periosteum: (1) the chondrocyte precursors
are located in the cambium layer of periosteum; (2) chondrogenesis commences in the juxtaosseous area in the cambium layer and
progresses from the juxtaosseous region to the juxtafibrous region of the cambium layer; (3) neocartilage growth is appositional, which
displaces the fibrous layer away from the cartilage already formed, as new cartilage is formed between these two layers. These findings
suggest that the least differentiated (stem or reserve) cells are located in the cambium layer furthest from the bone.
Clinical relevance: These findings show that the chondrocyte precursors are located in the cambium layer of periosteum. Preservation of this
layer is essential for chondrogenesis. As neocartilage growth is appositional, away from the fibrous layer, it can be expected that the new
cartilage deposited in and adjacent to a periosteal graft would be expected to be located on the side of the cambium layer, rather than on
the side of the fibrous layer of the graft. © 2001 OsteoArthritis Research Society International
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Articular cartilage has a limited potential to repair itself
when damaged or diseased1. Since it possesses neither a
blood supply nor a source of mesenchymal stem cells, a
reasonable approach for the repair of damaged cartilage
would be to transplant cells, or a tissue having chondro-
genic potential into the defect2–9. Mesenchymal stem cells
in periosteum have been shown to differentiate into neo-
chondrocytes in vivo and in vitro10–19. This is the scientific
basis for autologous periosteal grafting (periosteal
arthroplasty)20–22, which is under clinical investigation as a
treatment option to repair defects in articular cartilage23–25.
Periosteal chondrogenesis is a promising but, as yet,
poorly understood phenomenon. For example, the215chondrocyte precursors in periosteum have not been
identified specifically, but it would be important to do so.
Due to the mixed cell population in the periosteum, it will be
necessary to distinguish chondrocyte precursors from other
cell lines in the tissue in order to investigate the regulation
of chondrocyte differentiation from the precursor cells in the
periosteum, using a technique such as in-situ hybridization.
Also, it will eventually be valuable to know whether the
chondrocyte precursors and the osteoblast precursors
are one and the same cell population, or whether they
represent two distinct populations of cells in periosteum.
Periosteum contains two distinct layers: a thick, outer
fibrous layer and a thin, inner cambium layer which is
adjacent to the bone. In 1739, Duhamel observed that
bones grew in diameter, as did the trunk of a tree, by
depositing layer after layer of new tissue on the outside
surface26. He concluded that the deep surface of the
periosteum served the same purpose as the cambium did
for a tree, and thus coined the term ‘cambium layer’ of the
periosteum. In 1867, Ollier confirmed that the cambium
layer was the essential component of the periosteum with
respect to bone formation27. Hall et al., showed that if the
periosteum was removed surrounding a fracture, no carti-
lage was produced in the fracture callus28. Furthermore,
216 Y. Ito et al.: Chondrocyte precursor localizationMaterials and Methods
PERIOSTEAL EXPLANTS
A total of 120 periosteal explants (4.0 mm×3.0 mm)
were taken from the medial sides of both proximal tibiae of
30 two-month-old New Zealand white rabbits (i.e. two
explants per tibia and, therefore, four explants per rabbit).
These explants were cultured in a standard organ culture
system conducive for chondrogenesis, as described in
detail in the next section. Harvesting of the explants was
performed as previously described, using sharp sub-
periosteal dissection1. All periosteal explants were
obtained within 15 min of death to control for post mortem
effects on chondrogenic potential. Immediately after surgi-
cal harvesting, the periosteal explants were placed in
Dulbecco’s Modified Eagle Media (DMEM) (cat. no. 12100-
046; Life Technologies, Grand Island, NY), with 25 l/ml
HEPES buffer (Life Technologies), penicillin/streptomycin
(50 U/mg and 50 g/ml respectively) (cat. no. 15145-014;
Life Technologies) and 1 mM proline (Sigma Chemical, St.
Louis, MO) at 4°C for no more than 1.5 h prior to placement
in culture wells.Selection criteria for inclusion of the periosteal explants
in data were as follows. An explant had to have formed at
least some cartilage, whose histological characteristics
included a clear demarcation from surrounding non-
cartilaginous tissue, chondrocytes in well demarcated la-
cunae, and uptake of safranin O stain. There were five
possible exclusion criteria: (1) tissue damage during har-
vesting, with loss of the cambium layer (which contains the
chondrocyte precursors) of cells that are only delicately
adherent to the fibrous layer, (2) inadequate cartilage to
analyse, (3) absence of a clear distinction between the
fibrous and cambium layers, (4) preparation artifacts (fold-
ing, tearing, dehydration cleavage), and (5) improper orien-
tation during sectioning, so that the fibrous and cambium
layers were not included in each section. Neither the total
amount of cartilage formed nor chondrocyte cell size (or
variation in cell size) were criteria for inclusion or exclusion.
A total of 40 cultured explants that met these inclusion
criteria, and a total of 12 explants from day 0 were studied
and analysed to form the basis of this report. Eighty-eight of
108 explants that had been cultured (12 were analysed
without being cultured) formed a significant amount of
cartilage in large areas. The remaining 20 explants that had
been cultured either formed inadequate amounts of carti-
lage or cartilage that was inappropriate for analysis
because it was blended throughout the non-cartilaginous
regions of the explants. Forty-eight of the 68 explants that
were excluded had to be excluded because of meeting
other exclusion criteria, despite having formed adequate
amounts of cartilage for analysis.ORGAN CULTURE
The culture conditions were as reported in the periosteal
agarose explant model by O’Driscoll et al.11 Twenty-four-
well flat bottom culture plates (cat. no. 25820; Corning
Glass Works, Corning, NY) were prepared using previously
published techniques11. The wells were pre-coated with
high Tm agarose gel (cat. no. 162-0100; Bio-Rad
Laboratories, Richmond, CA). The explants were then
suspended in 1.0 ml of a 1:1 mixture of 1.0% low Tm
agarose gel (cat. no. 162-0017 Bio-Rad Laboratories) and
×2 normal concentration DMEM. The final suspension
medium contained 0.5% low Tm agarose gel, ×1 DMEM,
1 mM proline, penicillin/streptomycin (50 U/mg and 50 g/
ml) and 10 ng/ml of transforming growth factor-1 (TGF-1)
(TGF-1 from porcine platelets, cat. no. 101-B1, R & D
Systems, Minneapolis MN). TGF- was added for its ability
to induce and enhance chondrogenesis in periosteal
explants. The agarose gel was then allowed to fully congeal
at 4°C for 5 min. Each 1.0 ml gel layer was then covered
with 1.0 ml DMEM containing 10% fetal calf serum (FCS)
(cat. no. 26140-079; lot no. 36P6072; Life Technologies),
1 mM proline, penicillin/streptomycin (50 U/mg and 50 g/
ml), 25 g/ml Vitamin C, and 10 ng/ml TGF-1. The
medium above the gel layer was replaced every second
day. 10 ng/ml of TGF-1 was added for the first 2 days in
culture and 25 g/ml Vitamin C was added daily. Cultures
were maintained at 37°C and 5% CO2 mixed with room air
for up to 42 days.HISTOLOGY AND HISTOMORPHOMETRY
Explants were harvested after 0, 7, 14, 21, 28, 35 and
42 days of culture. Each explant was fixed in 4%although the fibrous layer of the periosteum regenerated,
the cambium layer did not. The data available from these
studies suggest that the cambium layer may be more
crucial than the fibrous layer for chondrogenesis, as it is for
osteogenesis. It would be useful to know that, as the cells
in the cambium layer are easily damaged and lost during
periosteal harvesting and transplantation1.
Nakahara et al. showed that periosteum had both osteo-
genic and chondrogenic potential19. During post-natal
development, radial growth of long bones involves the
differentiation of mesenchymal stem cells in the periosteum
directly to osteoblasts29. On the other hand, during
embryogenesis and fracture healing these mesenchymal
stem cells differentiate into neochondrocytes to produce
cartilage tissue that is later replaced by bone30.
Specific chondrocyte precursors in periosteum have not
yet been identified. To achieve our long-term objective
of understanding the mechanisms regulating periosteal
chondrogenesis for cartilage repair and for fracture healing,
it will be necessary to localize and identify the chondrocyte
precursors in periosteum. It will eventually be necessary
to purify the chondrocyte precursors from periosteum to
determine whether there is a population of cells that are
truly bipotential (with both chondrogenic and osteogenic
capacity) or two separate populations of monopotential
precursors. To this end, the initial step is to localize these
precursors in the periosteum.
An in vitro organ culture model that has been estab-
lished11 to study the process of periosteal chondrogenesis
mimics the events of chondrogenesis occurring during
cartilage repair by periosteal arthroplasty in vivo. This
whole tissue model, therefore, provides an opportunity to
identify the chondrocyte precursors generated from un-
differentiated mesenchymal stem cells in periosteum. In
the present investigation, the location of the developing
chondrocytes in periosteum was determined by studying
the spatio-temporal localization of Col. II mRNA and protein
in periosteum using in-situ hybridization and immunohisto-
chemical analysis in this organ culture model. Furthermore,
the progression of chondrogenic differentiation and the
direction of cartilage growth were evaluated in relation to
histological changes in the cambium and fibrous layers.
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4 h at 4°C, and embedded in paraffin. Serial histological
sections, 3 m in thickness, were cut perpendicular to the
original cambium surface of the periosteum. Staining was
performed with safranin O/fast green. Existence of both
fibrous and neocartilage in each section was checked.
Neocartilage was defined as those areas containing round
or oval chondrocytes in lacunae, surrounded by an extra-
cellular matrix that had a hyaline ground-glass appearance
and stained with safranin O. Histological observations
of developing periosteal neocartilage according to the
selection criteria were accomplished.
Computerized histomorphometric analyses were per-
formed using an SMI-Microcomp semiautomatic Image-
analysis system (Southern Micro Instruments, Inc., Atlanta,
GA) at each time period. Area measurements were made
for (1) the cambium layer, (2) the fibrous layer, and (3) the
neocartilage in each explant.IN-SITU HYBRIDIZATIONProbes for in-situ hybridization
We acquired the rabbit-specific Col. II cDNA sequences
(269 base pairs) by employing the strategy of ‘gene dig-
ging’31. It involves the amplification of a gene segment by
PCR using primers designed from nucleotide sequences of
Col. II cDNA that are conserved across many species. The
templates for the preparation of cRNA probes were gener-
ated by PCR using rabbit specific 5′ and 3′ primers
designed from the acquired sequences of Col. II. For the
anti-sense cRNA probe, the corresponding template had
a T7 promoter sequence at the 3′ end of the fragment
provided in the 3′ primer. Similarly for the sense cRNA
probe, the corresponding template had a T7 promoter
sequence at the 5′ end of the fragment provided in the
5′ primer. PCR amplified products including T7 promoters
were used as templates. Digoxigenin (DIG)-11-UTP-
labeled cRNA sense or anti-sense rabbit-specific probes for
Col. II were made from each template via in-vitro tran-
scription using the DIG-RNA Labeling Kit (Boehringer
Mannheim GmbH Biochemica, Mannheim, Germany)
according to the manufacturer’s instructions. The anti-
sense cRNA probe for GAPDH for positive controls and the
probe for Col. I were made in the same manner.In-situ hybridization
In-situ hybridization was performed according to the
following protocol based on the method described by
Nomura et al.32 Several parameters (proteinase K concen-
trations and treatment time, anti-DIG antibody concen-
trations and incubation time) were optimized for reliable
and repeatable results. The sections were deparaffinized
through xylene, and rehydrated through decreasing con-
centrations of ethanol. They were then treated with protein-
ase K at 37°C for 15 min, refixed in 4% paraformaldehyde/
sodium phosphate buffer, acetylated and dehydrated
through ethanol. The sections were then hybridized at 50°C
for 16 h in a hybridization solution containing DIG labeled
sense or anti-sense probes in a humidified chamber. After
hybridization, the sections were washed in 5×SSC
(1×SSC=0.15 M NaCl, 0.015 M sodium citrate) at 50°C,
then washed in 2×SSC, 50% formamide at 65°C for 30 min
and then treated with RNase A at 37°C for 30 min followed
by washes in 2×SSC and 0.2×SSC at 65°C for 20 mineach. Immunological signal detection of Col. I and Col. II
mRNAs was accomplished using anti-DIG antibodies and
4-Nitro blue tetrazolium chloride (NBT)/5-Bromo-4-chloro-
3-iodolyl-phosphate (BCIP) as a substrate. Sections incu-
bated with anti-sense GAPDH probes act as positive
controls. Sections incubated with sense Col. II probes act
as negative controls. Results were visualized using light
microscopy.Fig. 1. Representative photomicrographs of periosteal explants
cultured for 21 days stained with safranin O (left) and in-situ
hybridization for Col. II (right). The periosteal neocartilage was
visually divided into two zones of equal thickness: (A) juxtafibrous:
the zone adjacent to the fibrous layer and (B) juxtaosseous: the
zone adjacent to the original bone. Computerized histomorphomet-
ric measurements of the Col. II expression indices were taken in
both of the rectangular areas (0.071 mm2), the juxtafibrous area
(a) and juxtaosseous area (b) contained at least 40 cells and were
located in the center of each zone.QUANTIFICATION OF COL. II MRNA EXPRESSION
For analysis of the in-situ hybridization sections (Fig. 1),
the periosteal neocartilage was visually divided into two
zones of equal thickness: (A) juxtafibrous: the zone
adjacent to the fibrous layer and (B) juxtaosseous: the zone
adjacent to the original bone. Col. II mRNA expression was
quantified in both of the 0.071 mm2 rectangular areas
depicted in Fig. 1: in the juxtafibrous area (a) and in the
juxtaosseous area (b). Each area contained at least 40
cells and was located in the center of the juxtafibrous or
juxtaosseous zones respectively. In each explant, three
sites in the neocartilage were randomly sampled. Separate
measurements were made for the juxtafibrous and juxta-
osseous regions at each site, so that a total of six measure-
ments were obtained from each explant. Computerized
histomorphometric measurements of the Col. II expression
index (percentage of total cells that are Col. II mRNA
expression positive in each examined area) were carried
out by the same SMI-Microcomp semiautomatic Image-
analysis system referred to above. Each examination was
repeated twice, separated by at least a 2 week period to
ensure reproducibility and an average measurement was
used. The Col. II expression indices were measured in 126
sites in 21 explants on days 14–21 (three explants from day
14, six explants from day 21, three explants from day 28,
four explants from day 35 and five explants from day 42). In
each explant, three sites were sampled in the neocartilage.
Each site was divided into a juxtafibrous and juxtaosseous
region. The Col. II expression indices of the day 7
explants were not measured, because the total neo-
cartilage area was not large enough for measurement.
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To detect the localization of Col. II protein, immunohisto-
chemistry for Col. II was performed on the serial sections of
the periosteal explants. The following protocol was based
on the method reported previously by Hall et al.33 Several
parameters, namely endogenous peroxidase activity block-
ing time, primary antibody concentrations and incubation
time and reaction time with diaminobenzidine (DAB) solu-
tion, were optimized for reliable and repeatable results. The
sections were deparaffinized with xylene and hydrated with
serial concentrations of 100, 95, 80 and 60% ethanol.
Endogenous peroxidase activity was blocked with 0.6%
hydrogen peroxide in methanol for 60 min. Following a
tris-buffered saline wash (TBS)/0.1% bovine serum albu-
min (BSA) (cat. no. 81-003-N; lot no. 514; Bayer Corp.
Kankakee, IL), hyaluronidase treatment (hyaluronidase
1mg/ml in sodium acetate buffer, pH 5.5, 0.85% NaCl) was
performed for 30 min at 37°C. After being washed with
TBS/0.1% BSA, the sections were incubated with blocking
solutions (3 ml of fresh TBS/0.5% BSA with 39 l of normal
horse serum) at room temperature for 15 min. The sections
were then incubated with polyclonal antibodies to Col. I and
Col. II (Research Diagnostics Inc, Flanders, NJ), diluted at
1:400, at room temperature for 16 h. After a TBS/0.1% BSA
wash, incubation was carried out with biotinylated anti-
rabbit IgG for 1 h, followed by a TBS/0.1% BSA wash.
Vectastain (Burlingame, CA) ABC reagent was added for
30 min followed by TBS/0.1% BSA and TBS washes. The
sections were reacted with DAB solution for 3 min.
All incubations were performed in humid atmosphere
chambers.STATISTICAL ANALYSIS
All data are expressed as mean±S.D. Statistical analyses
were performed by a two-factor ANOVA and Duncan’s New
Multiple Range post-hoc testing.ResultsFig. 2. At the time of explantation, the cambium layer represented
approximately one-third of the total area of the periosteal explant,
or about half the area of the fibrous layer. By day 14, the area of
neocartilage had significantly increased and the cambium layer
decreased in area. The fibrous layer remained unchanged in area
during the whole culture period. As the size of the neocartilage
increased, the cambium layer diminished to the extent that by
21–28 days it was no longer evident. Each week there was a
significant increase in the amount of neocartilage until day 35, at
which time the area of neocartilage was 700% greater than the
original area of the cambium layer. The letters (A, B, C, a, b, c and
) indicate the results of post-hoc testing with Duncan’s multiple
range test at P<0.05. Any two groups with a letter in common are
not significantly different from each other.HISTOLOGICAL CHANGES IN EXPLANTS
A total of 40 separate explants (six explants from day 7,
eight explants from day 14, six explants from day 21, eight
explants from day 28, four explants from day 35 and eight
explants from day 42) formed cartilage that met the in-
clusion criteria, i.e. a well demarcated area of cartilage
formation that contained cells with the morphological char-
acteristics of chondrocytes (presence of a lacuna sur-
rounded by extracellular matrix that took up the safranin O
stain). These inclusion criteria were strict in order to permit
accurate interpretation and localization of cells. Twelve
explants from day 0 were used for the tissue analyses
before culture. Eighty-eight of the 108 explants that had
been cultured (12 were analysed without being cultured)
formed a significant amount of cartilage in large areas. The
remaining 20 explants that had been cultured either formed
inadequate amounts of cartilage or cartilage that was
inappropriate for analysis because it was blended through-
out the non-cartilaginous regions of the explants. Forty-
eight of the 68 explants that were excluded had to be
excluded because of meeting other exclusion criteria,
despite having formed adequate amounts of cartilage for
analysis.At the time of explantation the area of the cambium layer
(0.42 mm2±0.07 mm2) represented approximately one-
third of the total area of the periosteal explant, or about half
the size of the fibrous layer. Neocartilage first appeared in
the cambium layer on day 7, with immature small flat cells
in lacunae, surrounded by an extracellular matrix that
stained with safranin O (Fig. 2). All neocartilage developed
initially in the juxtaosseous region of the cambium layer
(i.e. that region that had been adjacent to the bone prior
to explantation). By day 14, the area of neocartilage
(0.69 mm2±0.43 mm2) had significantly increased, and the
cambium layer decreased in area (0.12 mm2±0.07 mm2)
(Fig. 2). The fibrous layer remained unchanged in area and
thickness. In fact, from 0 to 42 days, there was no signifi-
cant change (P=0.1052) in the cross-sectional area of the
fibrous layer (0.84 mm2±0.33 mm2) and there was no
evidence of hypertrophy or atrophy. However, with the
appearance of neocartilage in the cambium layer, the
thickness and area of the cambium layer diminished to
the extent that by 21 to 28 days it was no longer evident
(Fig. 2). Each week there was a significant increase in the
amount of neocartilage, until day 35, at which time the area
of neocartilage (2.57 mm2±0.54 mm2) was 700% greater
than the original area of the total cambium layer (Fig. 2).
The details of these observations at each time period are
described below.
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area of the cambium layer
On day 7, cells that could be identified as chondrocytes
appeared in the juxtaosseous region, i.e. that portion of the
cambium layer that had been lying immediately adjacent to
the bone prior to explantation (Fig. 3). These immature
chondrocytes were flat, surrounded by lacunae, and an
extracellular matrix that stained weakly with safranin O.
Such a pattern of cells and extracellular matrix was
observed in six of six explants. The total neocartilage area
was 0.20 mm2±0.13 mm2. Type II collagen (Col. II) mRNA
expression by in-situ hybridization, and the presence of
Col. II protein by immunostaining, were also evident in the
most juxtaosseous area of the cambium layer (Fig. 3). No
evidence of chondrogenesis was apparent in the juxta-
fibrous region, i.e. that portion of the cambium layer closer
to the fibrous layer (Fig. 3). The fibrous layer itself remained
unchanged without evidence of growth or chondrogenesis.Day 14: Chondrocyte differentiation progresses
from juxtaosseous to juxtafibrous area
By day 14, chondrogenesis had developed further into
the juxtaosseous region, with the conversion of flat imma-ture chondrocytes to small round cell chondrocytes in
seven of eight explants. An abundance of glycosaminogly-
cans in the extracellular matrix, as demonstrated by a
uniformly strong propensity for uptake of the safranin O
stain, indicated their maturity as functioning chondrocytes.
In these same seven explants, definite progression of
chondrocyte differentiation to the juxtafibrous region of the
cambium layer was apparent. The maturation process was
evidenced by the fact that the chondrocytes in the juxta-
fibrous region were flat, surrounded by lacunae, and an
extracellular matrix that stained weakly with safranin O,
just as those initially seen in the juxtaosseous region had
been on day 7. The total area of neocartilage was
0.69 mm2±0.43 mm2. One explant had only flat cells in
lacunae, and an extracellular matrix that stained weakly
with safranin O. Col. II mRNA expression and protein
production coincided with the extension of cartilage for-
mation, and were now evident in both the juxtafibrous and
juxtaosseous regions of all eight explants.Fig. 3. Representative sequential photomicrographs of periosteal explants cultured for 0, 7, 14, 21, 28, 35 or 42 days. The upper row is
safranin O stain. The middle row is in-situ hybridization for Col. II. The lower row is immunostaining for Col. II. C=cambium layer, F=Fibrous
layer, and N=Neocartilage (magnification=50×).Day 21: Chondrogenesis throughout cambium;
appositional cartilage growth; lamina splendens
Chondrogenesis was seen throughout the entire cam-
bium layer in five of six explants, and most of the cambium
layer in one explant. It was apparent that cartilage growth
was appositional, between the new cartilage and the
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cross-sectional area of neocartilage (1.34 mm2±0.34 mm2)
was significantly greater than on day 14 or day 7 (P<0.05).
The fibrous layer itself remained unchanged in histological
appearance and thickness. In every explant the entire
neocartilage in the cambium layer, which by now stained
uniformly strongly with safranin O, also showed abundant
Col. II mRNA expression and protein production, though
these were not present in the fibrous layer, which immuno-
stained for type I collagen and expressed Col. I mRNA.
In three of six explants, a ‘lamina splendens’ was present
on the surface of the neocartilage in the cambium layer. As
in articular cartilage, this consisted of a thin layer of small
flat cells aligned in a horizontal orientation. These cells
predominantly expressed, and were surrounded by an
extracellular matrix containing, type I collagen.Day 28: Declining Col. II mRNA in juxtaosseous
region of neocartilage
Further appositional cartilage growth was evident, on
the cambium side of the periosteal explants, in eight of
eight explants. The total area of neocartilage (1.94 mm2±
0.37 mm2) was significantly greater than on day 21 or
earlier (P<0.05). Col. II mRNA expression in the juxta-
osseous area had decreased in five of eight explants,
although the intensity of immunostaining for Col. II protein
did not change.Day 35: Declining Col. II mRNA in juxtafibrous
region of neocartilage
The total area of neocartilage (2.57 mm2±0.54 mm2)
was significantly greater than on day 28 or earlier (P<0.05).
Col. II mRNA expression in the juxtaosseous area
decreased further and that in the juxtafibrous area
decreased in three of four explants. Immunostaining for
Col. II protein remained intense and was present through-
out the whole neocartilage (N=4/4).Day 42: Matrix depletion in juxtaosseous region of
neocartilage
In four of eight explants, early signs of cartilage degen-
eration were seen in the peripheral juxtaosseous regions.
The changes included a depletion of extracellular matrix,
as evidenced by a decrease in safranin O staining and
expression of collagen II mRNA, with an increase in the
expression of collagen I mRNA. The total cartilage area
was 2.93 mm2±0.75 mm2. A decline in Col. II mRNA
expression decreased in both the juxtaosseous and juxta-
fibrous regions in six of eight explants. Although the
expression of Col. II mRNA changed, Col. II protein levels
did not. Col. II immunostaining remained strong throughout
the neocartilage (N=8/8). The thin (usually 1–2 cells thick)
layer of undifferentiated small cells on the surface of what
had been the osseous side of the cambium layer persisted
in the form of a lamina splendens in three of eight explants.
The extracellular matrix around these cells was sparse and
did not stain with safranin O, but did express Col. II mRNA.TIME COURSE OF COL. II EXPRESSION INDEX
Col. II mRNA expression were maximal on day 14, when
88%±3% of the cells in the cambium layer were positive forCol. II mRNA by in situ hybridization (Fig. 4). From day 21
to day 42, Col. II mRNA expression declined to 17%±7% of
the juxtaosseous and 43%±6% of the juxtafibrous cells
(P<0.05) (Fig. 4). The decline was more rapid and signifi-
cant in the juxtaosseous region, where only 30% of the
cells were still expressing Col. II mRNA on day 28
(P<0.0001) (Fig. 4).Fig. 4. The Col. II expression indices (percentage of the cells that
demonstrating chondrogenic activity by Col. II mRNA expression)
were maximal on day 14, then declined in both the juxtaosseous
and juxtafibrous regions between days 21 and 42. The decline was
more rapid and significant in the juxtaosseous regions (P<0.01).Discussion
The results of this study reveal three facts concerning
chondrogenesis from periosteum. First, the chondrocyte
precursors are located in the cambium layer of periosteum.
Second, chondrogenesis commences in the juxtaosseous
area in the cambium layer. Third, neocartilage growth is
appositional, away from the fibrous layer.
Our histological observations have confirmed persist-
ence of the fibrous layer during chondrogenesis, while
neocartilage developed in, and gradually replaced, the
cambium layer (Figs 2 and 3). In fact, by day 28, all but a
few of the cells present in the cambium layer were express-
ing the differentiated chondrocyte phenotype. Col. II mRNA
expression was never seen in the fibrous layer. These
results indicate that the chondrocyte precursors are located
in the cambium layer. To the best of our knowledge, this
is the first report confirming that periosteal chondrocyte
precursors are in the cambium layer. These findings
are consistent with observations previously made in
vivo.28,34–37. The cambium layer is known to be essential
for periosteal osteogenesis28,38, which is probably relevant
to periosteal chondrogenesis as well. Though some might
argue that periosteal chondrogenesis actually is osteogen-
sis, there is evidence suggesting that this is not the case for
this in-vitro model or in periosteal arthroplasty39. Periosteal
explants cultured in agarose for up to 48 weeks not only
survive but do so without any of the neocartilage turning
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of the cambium layer and progressed from juxtaosseous area to
juxtafibrous area in the cambium layer. Growth of regenerated
neocartilage is directional, away from the fibrous layer.into bone.39 Some areas of the cartilage exhibit mineral
deposition, but many do not. Furthermore, the majority of
the cartilage remains in a non-hypertrophic state with no
signs of progression towards bone formation. Therefore,
the process that we are observing is not merely endochon-
dral ossification. The same has been found with these
studies in vivo, in which the cartilage is able to be pre-
served long term (i.e. for a year)39. Although it is not known
whether the chondrocyte precursors and osteoblast precur-
sors arise from the same cells in periosteum, it is possible
that they do. If they do not, it is at least probable that they
reside in the same general region of the periosteum
responsible for growth and repair, i.e. the cambium layer.
Using tritiated thymidine labeling, Tonna and Cronkite have
shown that the cambium layer contains the osteoblast
precursor cells responsible for fracture repair38.
The fact that the chondrocyte precursors reside in the
cambium layer has several implications. It has previously
been shown that the total cell count in the cambium layer of
periosteum is significantly related to the chondrogenic
potential of periosteum17,40. This would explain the pre-
vious reports showing that the chondrogenic potential of
periosteum from different donor sites or ages varies
according to the total number of cells in the cambium
layer17,40. It would also explain why loss of cells from the
cambium layer, which is so easily damaged, results in loss
of chondrogenic potential1.
During periosteal chondrogenesis in vitro, chondrocyte
differentiation was first evident in the most juxtaosseous
area of the cambium layer, i.e. that region of the periosteum
that had been in contact with bone prior to explantation.
The most likely explanation is that the cells in the juxta-
osseous region are more differentiated than those further
away from the bone, in the juxtafibrous region. Tonna and
Gonkike showed by electron microscopic examination that
the degree of differentiation of the cells in the cambium
layer of the periosteum was related to their proximity to the
bone38,41. They reported the existence of a progenitor
compartment in the cambium layer consisting of cells that
undergo gradual cellular maturation and differentiation into
functional osteoblasts during membranous ossification. In
addition, the differentiation pattern of periosteum in vitro
was similar to that seen in subperiosteal injection of TGF-
in vivo36,37. Thus, the portion of the cambium layer furthest
from the bone would serve as a reservoir of undifferentiated
(stem) cells. If this explanation is correct, it might be
anticipated that the time in culture at which cartilage is first
seen would vary according to how much of the cambium
layer is preserved during harvesting. In other words, if the
most differentiated cells are retained on the bone rather
than being taken with the periosteum during harvesting, it
would take longer before chondrogenesis is evident. This
has been our experience exactly. We have consistently
observed in our laboratory that not only does the cartilage
yield obtained by different operators depend on the skill of
the operator, but also that the time required for chondro-
genesis to occur in the explants taken by these same
operators varies inversely with their skill (not shown).
A second possible explanation for chondrogenesis com-
mencing in the juxtaosseous area, would be that the cells
in this region of the periosteum are more directly affected
by the agarose or media nutrients in which the explants
are cultured. Benya et al. showed that chondrocytes
suspended in agarose take on a round shape that permits
expression of the chondrogenic phenotype42. Also, there
could be a gradient effect in which the cells at the surface of
the explants behave differently from those deeper, due togradients in oxygen tension, etc. However, periosteal chon-
drogenesis is optimal under aerobic conditions43. These
two explanations are less likely to be correct, as the only
difference we see is a time difference in how quickly the
cartilage appears in different regions of the periosteum.
This investigation provides evidence suggesting that the
precursors of osteoblasts and chondrocytes come from the
same cells in the periosteum. As stated above, the most
differentiated cells are those immediately adjacent to the
bone. If these cells are pre-osteoblasts (and no longer
capable of chondrocyte differentiation), it would be
expected that these cells would either remain undifferen-
tiated, become osteoblasts or die in culture. However,
almost all cells that were still present in that region of the
periosteum by day 28 had differentiated into chondrocytes.
It is unlikely that all cells not differentiating into chondro-
cytes had been somehow lost from the cambium layer
during culture. Thus, it would appear that even the
most differentiated cells in the cambium layer of the peri-
osteum remain in at least a bipotential state as pre-
osteochondrocytes. The hypothesis that periosteal
chondrogenesis and periosteal osteogenesis originate from
the same cell line might, at least partially, explain the
observation made by Iwaskaki et al.44 They found that the
amount of cartilage formed by periosteal cells in high
density culture was increased by TGF-1 at doses of
0.3–1.0 ng/ml, which caused a corresponding decrease in
the amount of bone formed. That observation could also be
interpreted to suggest a common cell line in periosteum for
both chondrogenesis and osteogenesis. These findings are
relevant to the regulation of endochondral ossification of
cartilage. The factors that determine whether cartilage will
be replaced by endochondral ossification in a system such
as this are not known, but clearly are relevant to fracture
healing as well as cartilage repair.
Chondrocyte differentiation progressed from the juxta-
osseous region to the juxtafibrous region of the cambium
layer during the first 28 days of culture (Fig. 3). A further
possible explanation arising from this observation would
involve a paracrine control mechanism whereby chondro-
genesis commences in the juxtaosseous region and
then releases cytokines and growth factors stimulating
chondrogenesis in the adjacent juxtafibrous region.
Growth of the neocartilage was directional appositional,
displacing the fibrous layer from the cartilage already
formed (Figs 3 and 5), just as the apposition of a new ‘‘ring’’
of wood in a tree trunk by the cambium displaces the tree
bark outwards in a radial direction. This direction of carti-
lage growth correlates precisely with what has been
reported during periosteal chondrogenesis in vivo1,36,37.
The orientation of the cambium layer was a determinant of
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arthroplasty10. When the periosteal grafts were placed onto
the subchondral bone with the cambium layer facing up into
the joint, the cartilage grew upwards to fill the defect and
the fibrous layer of the periosteum was gradually replaced
by bone. The results were significantly worse when the
cambium layer was placed facing down against the
subchondral bone10. In those cases, the fibrous layer was
displaced towards the joint surface by the cartilage growth
under the periosteum, leaving soft fibrous tissue where
there should be articular cartilage.
Persistence of the fibrous layer during periosteal chon-
drogenesis indicates that the orientation and location of
transplanted periosteum influences articular cartilage
repair. If periosteum is level with the joint surface, the
fibrous layer may persist or prevent complete cartilage
regeneration or bonding with the adjacent articular carti-
lage. It might also disturb the articulation by being dis-
placed above the joint surface as the neocartilage beneath
it grows appositionally. Periosteal transplantation was
originally designed so that the tissue should be grafted onto
the base of the defect into the subchondral bone1,12.
This study has permitted insight regarding the location of
the chondrocyte precursors of periosteum and suggested
that they may be the same cells as the osteoblast precur-
sors in the cambium layer. Such undifferentiated stem cells
reside in that part of the cambium layer that is farthest from
the bone. Future investigations will be necessary to isolate
and characterize the chondrocyte precursors and to deter-
mine the role of the fibrous layer. It is possible that cells in
the fibrous layer respond to mechanical stimuli by secreting
growth factors that act on the cambium cells via a paracrine
mechanism. This opens up a new direction of research
that can improve our understanding of the functions and
relationship between the cambium and fibrous layers of
periosteum.Conclusions
Chondrocyte precursors are located in the cambium
layer of periosteum. Chondrogenesis commences in the
juxtaosseous area in the cambium layer and progresses
from the juxtaosseous region to the juxtafibrous region of
the cambium layer. Neocartilage growth is appositional,
away from the fibrous layer.Acknowledgments
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